Midatech Pharma plc (MTPH)の価格はいくらですか

Midatech Pharma plc (MTPH)の価格は$0.05309195です

Midatech Pharma plc (MTPH)の時価総額は何ですか

Midatech Pharma plc (MTPH)の時価総額は$164.43です

Midatech Pharma plc (MTPH)価格と時価総額

Midatech Pharma plc operates as a pharmaceutical company specializing in drug delivery technologies. Its core activities revolve around the research and development of therapeutic compounds, with operations spanning the United Kingdom, broader Europe, and global markets. Currently, its pipeline includes several key developments: MTX110, an innovative direct-delivery therapy targeting diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immunosuppressant designed for topical use against psoriasis; MTD211, a sustained-release version of brexpiprazole intended for managing schizophrenia and as an add-on therapy for major depressive disorder; and MTD219, a prolonged-action formulation of tacrolimus aimed at reducing the likelihood of organ transplant rejection. Beyond its specific drug candidates, Midatech Pharma provides advanced drug delivery platforms. These include Q-Sphera, a microtechnology based on polymer microspheres that enables drugs to be released over extended periods; MidaSolve, a nanotechnology employing oligosaccharides to enhance drug solubility, allowing direct and localized administration into tumors; and MidaCore, a gold nanoparticle system engineered to precisely deliver chemotherapeutic or immunotherapeutic agents to disease sites. Established in 2000, the company maintains its headquarters in Cardiff, United Kingdom.

MTPHの価格	資産b	bの市場	結果
$1,752,014,376 $164.43	NVDA	$5.426T	+3,299,962,556,008.80%
$1,429,420,721 $164.43	AAPL	$4.427T	+2,692,349,400,066.17%
$1,336,438,338 $164.43	GOOG	$4.139T	+2,517,214,773,881.52%
$1,180,511,362 $164.43	MSFT	$3.656T	+2,223,522,446,682.19%
$931,755,202 $164.43	AMZN	$2.886T	+1,754,984,045,411.35%

MTPHの価格

資産b

bの市場

結果

$1,752,014,376 $164.43